Nan Jia et al. [25] demonstrated that EZH2 was overexpressed (medium to strong reactivity) in complex hyperplasia, atypical hyperplasia, and endometrial cancer, but not in simple hyperplasia and normal endometrium (with negative to weak expression). The gene discussed is EZH2; the disease is endometrial cancer.